{"version":"1.0","provider_name":"Basel Area Business &amp; Innovation","provider_url":"https:\/\/test.baselarea.swiss\/de\/","author_name":"martin","author_url":"https:\/\/test.baselarea.swiss\/de\/author\/martin\/","title":"Sumitovant erwirbt alle Aktien von Myovant","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"UDTM0RT9MM\"><a href=\"https:\/\/test.baselarea.swiss\/de\/blog-post\/sumitovant-sumitomo-pharma-myovant-sciences\/\">Sumitovant erwirbt alle Aktien von Myovant<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/test.baselarea.swiss\/de\/blog-post\/sumitovant-sumitomo-pharma-myovant-sciences\/embed\/#?secret=UDTM0RT9MM\" width=\"600\" height=\"338\" title=\"&#171;Sumitovant erwirbt alle Aktien von Myovant&#187; &#8212; Basel Area Business &amp; Innovation\" data-secret=\"UDTM0RT9MM\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/test.baselarea.swiss\/\/wp-content\/uploads\/2020\/04\/Healthcare_doctor-and-patient-ipad-e1666625229959.jpg","thumbnail_width":800,"thumbnail_height":566,"description":"Sumitovant macht die Basler Firma Myovant Sciences zu ihrer hundertprozentigen Tochterfirma und erwirbt alle Aktien von Myovant f\u00fcr 27 Dollar pro Aktie in bar. Das entspricht einem Unternehmenswert von 2,9 Milliarden Dollar. Sumitovant besitzt aktuell 52 Prozent der Aktien von Myovant."}